Evaluating Mortality Risk Adjustment Among Children Receiving Extracorporeal Support for Respiratory Failure

Ryan P Barbaro1,2, Philip S Boonstra3, Kevin W Kuo4

  • 1From the Division of Pediatric Critical Care, University of Michigan, Ann Arbor.

ASAIO Journal (American Society for Artificial Internal Organs : 1992)
|May 11, 2018
PubMed

Insights

Pediatric Risk of Mortality Score (PRISM) III, Pediatric Index of Mortality (PIM) 2, and Pediatric Logistic Organ Dysfunction (PELOD) scores poorly predict mortality in pediatric extracorporeal membrane oxygenation (ECMO) patients. The Ped-RESCUERS score, enhanced with clinical data, offers improved mortality prediction for these critically ill children.

Area of Science:

  • Pediatric Critical Care Medicine
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Medical Scoring Systems

Background:

  • Pediatric intensive care unit (PICU) severity of illness scores are crucial for risk stratification.
  • Existing scores like PRISM III, PIM 2, and PELOD may not accurately reflect mortality risk in children on ECMO for respiratory failure.
  • The need for ECMO-specific risk assessment tools is critical for this vulnerable population.

Purpose of the Study:

  • To evaluate the ability of PRISM III, PIM 2, and PELOD to discriminate mortality in pediatric ECMO patients.
  • To assess the performance of the Pediatric Risk Estimate Score for Children Using Extracorporeal Respiratory Support (Ped-RESCUERS) in this population.
  • To determine if adding clinical and laboratory data improves Ped-RESCUERS' mortality discrimination.

Main Methods:

  • Multi-institutional retrospective cohort study of pediatric patients (29 days to 17 years) receiving respiratory ECMO.
  • Mortality discrimination assessed using Area Under the Receiver Operating Curve (AUC).
  • Model calibration evaluated with Hosmer-Lemeshow test and Brier score.

Main Results:

  • PRISM III, PIM 2, and PELOD demonstrated poor mortality discrimination (AUCs: 0.56, 0.53, 0.57).
  • Ped-RESCUERS showed better performance (AUC: 0.68).
  • Incorporating alanine aminotransferase, oxygenation index, and lactic acidosis into Ped-RESCUERS improved AUC to 0.75.

Conclusions:

  • General PICU severity scores (PRISM III, PIM 2, PELOD) are inadequate for pre-ECMO risk adjustment.
  • Ped-RESCUERS demonstrates superior discrimination for pediatric ECMO patients.
  • ECMO-specific scoring systems derived from ECMO populations are recommended over general PICU scores for risk adjustment.

Related Concept Videos

Renal Failure: Dose Adjustments01:11

Renal Failure: Dose Adjustments

In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
492
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
515
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
940
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
578